To create LymphoStat-B, HGS devised an antibody that binds to BLYS and inactivates it.

FORBES: Magazine Article

They created strains of genetically engineered mice that produced excessive levels of BLYS and, sure enough, developed lupuslike symptoms.

FORBES: Magazine Article

Stohl realized BLYS might provide a way to create a targeted new drug that reduced autoantibodies without causing this collateral damage.

FORBES: Companies & Strategies